The imported value of opacifying preparations, X-ray, and diagnostic reagents to Japan is projected to decrease steadily from $183.66 million in 2024 to $170.48 million by 2028. Compared to 2023, this represents a continuing decline. The year-on-year decreases range from approximately 1.66% to 1.88% during these forecast years. The Compound Annual Growth Rate (CAGR) over the five forecasted years indicates a moderate annual decline in imports.
Future trends to watch for include Japan's increasing emphasis on domestic production and technological innovation in the medical reagent sector, which may further reduce import reliance. Additionally, global supply chain dynamics and trade policies could impact import levels.
